ACRO Recommendations to Independent Review of the State of Commercial Clinical Trials in the UK

As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to United Kingdom in 2023 about ACRO Recommendations to Independent Review of the State of Commercial Clinical Trials in the UK can be found below.

ACRO Recommendations to Independent Review of the State of Commercial Clinical Trials in the UK

Scroll to Top